NO983452D0 - Procedures for Inhibiting Musculoaponeurotic Fibromatosis (Desmoid Tumors) - Google Patents
Procedures for Inhibiting Musculoaponeurotic Fibromatosis (Desmoid Tumors)Info
- Publication number
- NO983452D0 NO983452D0 NO983452A NO983452A NO983452D0 NO 983452 D0 NO983452 D0 NO 983452D0 NO 983452 A NO983452 A NO 983452A NO 983452 A NO983452 A NO 983452A NO 983452 D0 NO983452 D0 NO 983452D0
- Authority
- NO
- Norway
- Prior art keywords
- procedures
- desmoid tumors
- inhibiting
- fibromatosis
- musculoaponeurotic fibromatosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1077396P | 1996-01-29 | 1996-01-29 | |
| GBGB9603148.9A GB9603148D0 (en) | 1996-02-15 | 1996-02-15 | Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
| PCT/US1997/002287 WO1997026878A1 (en) | 1996-01-29 | 1997-01-27 | Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO983452L NO983452L (en) | 1998-07-27 |
| NO983452D0 true NO983452D0 (en) | 1998-07-27 |
Family
ID=26308707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO983452A NO983452D0 (en) | 1996-01-29 | 1998-07-27 | Procedures for Inhibiting Musculoaponeurotic Fibromatosis (Desmoid Tumors) |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0907361A4 (en) |
| JP (1) | JP2000503995A (en) |
| KR (1) | KR19990082055A (en) |
| CN (1) | CN1209746A (en) |
| AU (1) | AU707675B2 (en) |
| CZ (1) | CZ235398A3 (en) |
| EA (1) | EA199800678A1 (en) |
| IL (1) | IL125523A0 (en) |
| NO (1) | NO983452D0 (en) |
| PL (1) | PL328127A1 (en) |
| WO (1) | WO1997026878A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2135195C1 (en) * | 1998-12-17 | 1999-08-27 | Овсюк Валерий Григорьевич | Method for producing material containing prostate cells and treating the cases of uterine fibromatosis, chronic prostatitis and male sexual function disorders by applying transplantation method |
| AU781168B2 (en) * | 2001-01-26 | 2005-05-12 | Pfizer Products Inc. | Method of treating certain cancers using an estrogen agonist/antagonist |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
| US5552162A (en) * | 1993-02-09 | 1996-09-03 | Arch Development Corporation | Method for improvement of scar size and appearance |
| US5457116A (en) * | 1993-10-15 | 1995-10-10 | Eli Lilly And Company | Methods of inhibiting uterine fibrosis |
| JPH07149638A (en) * | 1993-10-15 | 1995-06-13 | Eli Lilly & Co | Method for medical treatment of resistant neoplasm |
| US5574047A (en) * | 1993-12-21 | 1996-11-12 | Eli Lilly And Company | Methods of inhibiting imperfect tissue repair |
-
1997
- 1997-01-27 EA EA199800678A patent/EA199800678A1/en unknown
- 1997-01-27 AU AU21240/97A patent/AU707675B2/en not_active Ceased
- 1997-01-27 PL PL97328127A patent/PL328127A1/en unknown
- 1997-01-27 KR KR1019980705776A patent/KR19990082055A/en not_active Application Discontinuation
- 1997-01-27 CN CN97191916A patent/CN1209746A/en active Pending
- 1997-01-27 JP JP9527133A patent/JP2000503995A/en active Pending
- 1997-01-27 WO PCT/US1997/002287 patent/WO1997026878A1/en not_active Application Discontinuation
- 1997-01-27 IL IL12552397A patent/IL125523A0/en unknown
- 1997-01-27 EP EP97906588A patent/EP0907361A4/en not_active Withdrawn
- 1997-01-27 CZ CZ982353A patent/CZ235398A3/en unknown
-
1998
- 1998-07-27 NO NO983452A patent/NO983452D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO983452L (en) | 1998-07-27 |
| EP0907361A4 (en) | 2002-05-02 |
| PL328127A1 (en) | 1999-01-18 |
| CZ235398A3 (en) | 1999-02-17 |
| EA199800678A1 (en) | 1999-02-25 |
| WO1997026878A1 (en) | 1997-07-31 |
| EP0907361A1 (en) | 1999-04-14 |
| KR19990082055A (en) | 1999-11-15 |
| JP2000503995A (en) | 2000-04-04 |
| AU2124097A (en) | 1997-08-20 |
| CN1209746A (en) | 1999-03-03 |
| AU707675B2 (en) | 1999-07-15 |
| IL125523A0 (en) | 1999-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69635311D1 (en) | ELECTROCHIRUGIC TISSUE REMOVAL | |
| FR2724208B1 (en) | TELESCOPIC SYSTEM | |
| DE69733624D1 (en) | Image-controlled surgical system | |
| ITBO970195A0 (en) | SURGICAL EQUIPMENT FOR BIOPSY. | |
| NO974972L (en) | Procedure for preventing breast cancer | |
| BR9509015A (en) | 5alpha-reductase inhibitors | |
| FR2766349B3 (en) | CABINET DEODORIZATION SYSTEM | |
| ID17723A (en) | COMPOUND FOR TREATMENT | |
| NO983090D0 (en) | Therapeutic compounds | |
| ID23373A (en) | PHARMACEUTICAL COMPOSITIONS THAT CONTAIN N-SULFONYLINDOLIN DEPOSITS | |
| DE59703216D1 (en) | Drawer slide | |
| NO983452D0 (en) | Procedures for Inhibiting Musculoaponeurotic Fibromatosis (Desmoid Tumors) | |
| IDP000008233A (en) | BREAST CANCER PREVENTION METHOD | |
| DE59703287D1 (en) | Drawer slide | |
| FI970717A0 (en) | Methods for inhibiting uterine cancer | |
| DE69720957T2 (en) | ACE INHIBITORS | |
| DE29604090U1 (en) | Stand console | |
| ITBO960033A0 (en) | SURGICAL EQUIPMENT FOR BIOPSY | |
| GB9603148D0 (en) | Methods of inhibiting musculoaponeurotic fibromatoses (desmoid tumors) | |
| ID19472A (en) | NEW IMPROVEMENT FORMULATION FOR TROMBOEMBOLISM TREATMENT | |
| FI972182A (en) | Protection for easier surgical procedures | |
| ES1031551Y (en) | NEW STRUCTURE FOR TABLE GAMES. | |
| DE29615953U1 (en) | Drawer slide | |
| DE29605287U1 (en) | Scaffolding console | |
| HUP9901961A3 (en) | Use of benzotiophene derivatives for producing pharmaceuticals inhibiting musculoaponeurotic fibromatoses (desmoid tumors) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |